Charles Elliott Sigal
CIK 1661908 · last filed 2026-05-28
Charles Elliott Sigal is a corporate insider who has filed 35 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for VIR, was dated May 28, 2026. Across all open-market trades the lifetime net is +$338.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $96.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$96.95M
5
35
$338.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | Director | 49,806 | $11.63 | $579.2K | $246.3K | 11 | 2026-05-28 |
| ALNY | Director | 3,446 | $246.11 | $848.1K | $0 | 5 | 2026-05-22 |
| Surface Oncology, Inc. (SURF) Delisted | Director | 0 | $1.07 | $0 | $0 | 9 | 2023-09-08 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 4 | 2023-07-03 |
| ASND | Director | 367,038 | $260.25 | $95.52M | $92.1K | 6 | 2019-07-03 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2026-05-22 | ALNY | Grant (A) | +671 | $0 | EDGAR |
| 2025-06-02 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2025-05-12 | ALNY | Grant (A) | +775 | $0 | EDGAR |
| 2024-06-03 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2024-05-20 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2023-09-08 | Surface Oncology, Inc. (SURF) Delisted | Disp (D) | −45,453 | $0 | EDGAR |
| 2023-07-03 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-24 | VIR | Grant (A) | +6,027 | $0 | EDGAR |
| 2023-05-19 | ALNY | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.